Ufp Technologies Inc

  • Earnings Score
  • Moat Score
  • Safety Score
  • Final Score
  • Market Cap $2.06B
  • PE 38
  • Debt $224.50M
  • Cash $16.36M
  • EV $2.27B
  • FCF $45.47M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$54.21M
EBIT$71.38M
ROE16%
ROA11%
FCF$45.47M
Equity$329.15M
Growth Stability93%
PE37.96
PEG1.05
PB6.25
P/FCF45.27
P/S4.46
Price/Cash0.01
Debt/Equity0.68
Debt/FCF4.94
Net Margins12%
Gross Margins28%
Op. Margins15%
Earnings CAGR26%
Sales Growth YoY44%
Sales Growth QoQ32%
Sales CAGR15%
FCF CAGR21%
Equity CAGR13%
Earnings Stability0.87
Earnings Growth YoY40%
Earnings Growth QoQ21%
Earnings CAGR 5Y36%
Sales CAGR 5Y25%
FCF CAGR 5Y8%
Equity CAGR 5Y16%
Earnings CAGR 3Y30%
Sales CAGR 3Y30%
FCF CAGR 3Y187%
Equity CAGR 3Y21%
Market Cap$2.06B
Revenue$461.85M
Assets$638.51M
Total Debt$224.50M
Cash$16.36M
Shares Outstanding7.66M
EV2.27B
Earnings Score95%
Moat Score93%
Safety Score85%
Final Score91%
Working Capital122.66M
Current Ratio2.57
Gross Profit$130.77M
Shares Growth 3y1%
Equity Growth QoQ6%
Equity Growth YoY21%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing highly specialized foams, films, and plastics primarily for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

SEC Filings

Direct access to Ufp Technologies Inc (UFPT) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Ufp Technologies Inc compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Ufp Technologies Inc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 26%
Stability 87%
loading chart...

Ufp Technologies Inc Discounted Cash Flow

Fully customizable DCF calculator online for Ufp Technologies Inc.

= $2B
012345678910TV
fcf$45M$55M$66M$80M$97M$117M$142M$172M$208M$251M$303M$3B
DCF$50M$55M$60M$66M$73M$80M$88M$97M$106M$117M$1.2B
Value$2B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins5%5%6%8%10%7%8%12%11%12%
ROA-10%9%10%13%8%6%15%14%11%
ROE-7%7%10%12%8%8%18%16%16%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF-0.82-1.76-08.8814.881.174.94
Debt over Equity0.030.02-0.2-00.410.250.130.68
Growth Stability---100%100%93%100%100%100%93%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-5%1%29%4%-10%15%71%13%25%
Earnings YoY growth-5%16%55%38%-32%19%163%8%36%
Equity YoY growth-9%9%14%15%9%10%22%20%16%
FCF YoY growth--165%237%124%60%-19%-57%-55%678%8%